What Дисульфирам Treats: Main Uses and Benefits

Дисульфирам is commonly used to help with the long-term management of chronic alcoholism and Alcohol Use Disorder (AUD). This medication is applied in addressing conditions marked by increased physiological stress due to persistent alcohol dependence. The therapeutic approach is aimed at supporting continuous sobriety, which supports patients in managing symptoms that interfere with daily functioning due to compulsive drinking behavior.

The primary indications include chronic alcoholism and Alcohol Use Disorder in the moderate to severe range. It may assist with managing the overall symptom load and supports patients during episodes of impaired control over alcohol intake.

“The continuous support provided by the agent helps maintain a sense of stability when symptoms are more noticeable and the risk of relapse is present.”

Supporting Sustained Abstinence and Relapse Prevention

The medication provides support that helps ease the overall symptom burden associated with the chronic high risk of relapse. It assists with maintaining functional stability by reinforcing a continuous state of abstinence and helps patients cope more steadily with symptom fluctuations. This supportive agent is commonly used as an adjunct to psychosocial treatment for motivated individuals who have achieved initial sobriety.

---

Quick Fact: Management for High Risk of Relapse The medication plays a role in managing the frequent and intense recurrence pattern characteristic of chronic alcohol dependence.

Regulatory References

1. DailyMed/National Library of Medicine on Disulfiram

Who Can and Cannot Use Disulfiram

The eligibility for Disulfiram use is strictly defined by regulatory authorities and centers on adult patients committed to abstinence from alcohol. The use of this medicine is contraindicated and must be avoided in several populations due to significant risks.

Absolute Contraindications

Condition / Population	Status
Alcohol Consumption (within 12 hours)	Prohibited
Severe Myocardial Disease or Coronary Occlusion	Contraindicated
Psychosis or Severe Mental Illness	Contraindicated
Use of Metronidazole or Paraldehyde	Contraindicated
Hypersensitivity to Disulfiram or Thiuram Derivatives	Contraindicated

Conditional Use and Restrictions

Usage requires caution and close monitoring for patients with liver disease (hepatic impairment), kidney disease (renal impairment), diabetes mellitus, epilepsy, or severe lung disease. The medicine should not be given to nursing mothers.

Safety and effectiveness have not been established in pediatric patients, and use in pregnancy is advised only if the probable benefits outweigh the potential risks. For older adults, careful dosage selection is necessary, often starting at a lower range.

Interactions with other medicines and products

The official regulatory profile for Disulfiram is structured around absolute prohibitions and clinically significant pharmacokinetic effects.

Contraindicated Combinations and Substances

Substance	Regulatory Status	Constraint
Alcohol (Ethanol)	Absolute Contraindication	Prohibited due to the risk of the severe Disulfiram-Ethanol Reaction. This restriction extends to alcohol-containing food, topical products, and medications.
Metronidazole	Contraindicated Combination	Prohibited due to documented risk of toxic psychoses and adverse central nervous system effects.
Paraldehyde	Contraindicated Combination	Prohibited due to the risk of increased blood acetaldehyde levels.

Pharmacokinetic (Enzyme Inhibition) Interactions

Disulfiram is documented as an inhibitor of drug-metabolizing enzymes, notably Cytochrome P450 (CYP), leading to reduced clearance and increased systemic exposure of several co-administered medicines.

Interacting Drug/Class	Official Outcome Description
Oral Anticoagulants (e.g., Warfarin)	Increased anticoagulant effect and prolonged prothrombin time.
Anticonvulsants (e.g., Phenytoin)	Increased plasma concentrations, with potential for toxicity.
Theophylline & Benzodiazepines	Increased serum levels due to reduced clearance.

Other Constraints

Use with Isoniazid may result in a pharmacodynamic interaction leading to an increased risk of additive CNS toxicity. A mandatory timing rule requires that Disulfiram must not be administered until at least 12 hours after the patient has consumed alcohol. Severe Hepatic Impairment is noted as a condition that heightens the risk of interaction severity with co-administered drugs.

How Дисульфирам Works

---

Irreversible Inactivation of Aldehyde Dehydrogenase

The core action of Disulfiram involves its active metabolite forming an irreversible covalent bond with the Aldehyde Dehydrogenase ( ALDH2) enzyme, the primary enzyme responsible for converting acetaldehyde to acetate during alcohol metabolism. This highly specific mechanism permanently blocks the second step of ethanol breakdown, halting the clearance of the toxic intermediate.

---

Toxic Accumulation and Systemic Acute Response

Because the ALDH2 enzyme is inactivated, any subsequent intake of ethanol leads to the rapid and massive systemic accumulation of the toxic aldehyde. High concentrations of acetaldehyde directly cause profound peripheral vasodilation (flushing), autonomic system over-activation (tachycardia and hypotension), and severe gastrointestinal distress (nausea and vomiting), resulting in a severe, acute systemic physiological response.

---

⏳ Mechanism Duration and Enzyme Restoration

The drug's mechanism is characterized by the long duration of its effect, a consequence of the irreversible nature of the enzyme inhibition. The body must synthesize entirely new ALDH2 enzyme protein to restore metabolic function, meaning the potential for the severe physiological response persists for several days after the final dose, reflecting the time required for enzyme restoration.

Administration and Dosing

Дисульфирам is administered exclusively by the oral route (tablet form). It is intended for continuous, uninterrupted use and is utilized as an adjunct to supportive and psychotherapeutic treatment.

---

Dosing Schedule

Administration must not begin until the patient has abstained from alcohol for at least 12 hours. The standard adult regimen is divided into two phases:

Phase	US Labeled Dose Range	Frequency
Initial	Maximum 500 mg daily for 1 to 2 weeks.	Once daily
Maintenance	125 mg to 500 mg daily (average 250 mg).	Once daily

In some regions, the maintenance dose may be lower, sometimes ranging from 100 mg to 200 mg daily.

---

Administration Specifics and Special Rules

The once-daily dose is typically taken in the morning, but may be taken on retiring (at bedtime) if a sedative effect is experienced. For ease of ingestion, the tablet can be crushed and mixed with liquids such as water, coffee, tea, milk, or fruit juice.

Missed Dose: If a dose is missed, it should be taken as soon as remembered. If it is almost time for the next scheduled dose, the missed dose should be skipped; a double dose must never be taken to compensate.

Population: Safety and effectiveness have not been established in pediatric patients. For older adults, dose selection should be cautious, often starting at the lower end of the dosing range.

Research Evidence Base for Alcohol Use Disorder (AUD)

The core evidence for Disulfiram comes from various types of research, including Randomized Controlled Trials (RCTs) and Systematic Reviews that combine data from many different studies. These research efforts was evaluated in adults diagnosed with Alcohol Use Disorder (AUD) or chronic alcoholism. Research typically explored the use in populations where the medication was observed to be used as an adjunct to psychosocial treatment during the study period.

Researchers primarily examined specific measurements known as outcomes. The main outcomes measured in these studies included continuous abstinence, time to relapse, and measurements of alcohol consumption frequency. These measurements relate to conditions characterized by fluctuating or episodic manifestations of alcohol dependence.

---

The Role of Supervised Administration in Trial Findings

Research describes patterns observed in clinical trials, noting that the setting in which the medication is taken was associated with the measurements reported. Studies monitored the medication's use in two primary ways: when the patient's intake was supervised by a healthcare professional or caregiver, and when it was unsupervised.

The findings describe patterns where reported measurements of continuous abstinence were observed in some studies conducted in supervised treatment settings. Conversely, trials where medication intake was unsupervised reported results that were often mixed or findings were mixed when compared to a control group. This research provides insight into short-term changes and describes what has been observed so far regarding the difference in outcomes based on how the treatment was evaluated in the studies.

---

Consistency, Limitations, and Unanswered Questions

The evidence contributes to understanding symptom patterns, but is noted for its high heterogeneity, meaning the measurements and methodologies varied across different trials. This variability in how studies were conducted is a key research limitation.

Another major limitation is noted as the inherent difficulty in using standard blinded trial designs due to the medication's nature, which complicates the interpretation of findings independent of external factors like supervision or patient motivation. The evidence highlights what is known—and what is still uncertain—with long-term outcomes remaining uncertain and subgroup findings being uncertain.

Key Studies & References

1. ANTABUSE® (Disulfiram Tablets USP) IN ALCOHOLISM - FDA Prescribing Information / DailyMed

Common questions about Дисульфирам (FAQ)

---

Q: How long does the reaction last if alcohol is accidentally consumed?

According to official product information, the severity and duration of the disulfiram-alcohol reaction are variable. Symptoms are reported to last from 30 to 60 minutes, but may persist for several hours in more severe instances until the alcohol is cleared from the bloodstream.

---

Q: Is Дисульфирам considered a cure for alcohol use disorder, or is it a form of supportive treatment?

Regulatory documents classify Disulfiram as an aid in the management of chronic alcohol use disorder. It is intended to be used as an adjunct (supplement) to other comprehensive treatments, such as supportive care and psychotherapeutic treatment. Regulatory documents do not describe it as a standalone cure.

---

Q: How is Дисульфирам different from other medications used for alcohol treatment, such as Naltrexone?

Disulfiram has a unique mechanism compared to some other medicines, as it is classified as an Acetaldehyde dehydrogenase inhibitor. This mechanism is described as physically blocking the metabolism of alcohol to create an aversive state. Official information describes it as an Agent for the treatment of chronic alcoholism.

---

Q: Does Дисульфирам help reduce alcohol cravings or is its effect purely a deterrent?

The medication's function is officially described as that of an aversive agent. Its purpose is to create a strong physical sensitization to alcohol, which acts as a deterrent and supports a patient’s goal of sustained abstinence.

---

Q: Can Дисульфирам be used for conditions other than alcohol use disorder?

Official regulatory documents specify the use of Disulfiram solely as an aid in the management of chronic alcohol patients. The labeled indication is limited to its use in managing chronic alcohol use.

---

Q: Can Дисульфирам affect vision or cause eye pain?

The official safety profile notes that rare instances of neurotoxicity (effects on the nervous system) are a recognized risk. Reported instances include effects such as optic neuritis and occasional mentions of eye pain or tenderness.

---

Q: Why do some people experience a metallic or garlic-like taste when taking Дисульфирам?

According to official side effect reports, some patients may experience a metallic taste or a garlic-like taste in the mouth. This is listed among the less common side effects associated with the medication.

---

Q: Can Дисульфирам cause skin rashes, itching, or acne?

The official safety profile includes skin rash and acne among the less common side effects that have been reported with Disulfiram use.

---

Q: Are there reports of sexual side effects, like decreased libido or erectile dysfunction, with Дисульфирам?

The official safety profile reports a change in sex drive or performance as a possible side effect. This may include instances of decreased sexual ability in males.

---

Q: Should I be concerned about alcohol content in foods like vinegar, sauces, or certain baked goods while taking Дисульфирам?

Regulatory guidance advises patients to avoid alcohol-containing foods due to the risk of a reaction. This warning specifically extends to products like certain sauces and vinegars.

---

Q: Is there a risk of interaction if Дисульфирам is taken with blood thinners?

Official information notes that Disulfiram can interact with certain Oral Anticoagulants (often referred to as blood thinners), such as Warfarin. This action is noted to increase the anticoagulant effect due to the drug’s reduced clearance from the body.

---

Q: Can environmental exposure to alcohol fumes (e.g., paint, solvents) trigger a Дисульфирам-alcohol reaction?

Regulatory warnings state that the disulfiram-alcohol reaction has been reported in patients exposed to environmental chemical compounds containing alcohol. This risk extends beyond just topical products and internal consumption.

---

Q: Are there alternative dosage forms of Дисульфирам besides tablets?

While the primary dosage form for oral administration is the tablet, official descriptions also list specialized forms such as implants and injection solutions that are used for parenteral (non-oral) delivery.

---

Q: What is the information available regarding the use of Дисульфирам during pregnancy or while breastfeeding?

Official product information advises that the use of Disulfiram during pregnancy should only occur if the potential benefits are determined to outweigh the possible risks. Additionally, its use is advised against for nursing mothers due to the unknown nature of its excretion into human milk.

---

Q: What warnings exist for patients with an underactive thyroid (hypothyroidism) and Дисульфирам?

Official product information indicates that Disulfiram requires extreme caution in patients who have an underactive thyroid, medically known as hypothyroidism. This warning is due to the possibility that an accidental disulfiram-alcohol reaction could potentially make the thyroid condition worse.

---

Q: Does taking Дисульфирам affect the body's natural metabolism of other substances?

Regulatory documents describe Disulfiram as an inhibitor of drug-metabolizing enzymes, specifically the Cytochrome P450 (CYP) system. This action means that the medication may decrease the rate at which certain other drugs and substances are broken down (metabolized) by the body.

---

Q: Do people build a tolerance to the effects of Дисульфирам over time?

According to the official drug label's clinical pharmacology section, prolonged administration of Disulfiram does not produce tolerance. This means the deterrent mechanism is expected to remain consistent over the course of treatment.

---

Q: Are there specific warnings for using Дисульфирам in older adult populations?

Official information describes the need for cautious dose selection, often starting at the lower end of the available dosing range. This is often noted for older adult populations.

---

Q: Are there any diet or food restrictions to follow while taking Дисульфирам?

The primary restriction is the avoidance of alcohol-containing foods. Official guidance advises reading the ingredient list on all foods and products to identify and help prevent the accidental consumption of alcohol.

---

Q: Is it true that Дисульфирам can interact with certain prescription painkillers?

Disulfiram is documented to inhibit certain drug-metabolizing enzymes, which can lead to reduced clearance of some co-administered medicines. Officially noted examples of interacting drugs include those in the phenytoin and theophylline classes.

How to Store and Dispose of Disulfiram

Disulfiram must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. The medicine must be kept in a tightly closed container and protected from light to maintain product stability.

Child Safety and Handling

It is mandatory to store Disulfiram out of the reach of children.

Disposal Requirements

Unused or expired Disulfiram should be disposed of through a drug take-back program. If a program is unavailable, mix the medicine with an undesirable substance (e.g., used coffee grounds) and place the mixture in a sealed plastic bag for household trash. The medication must not be flushed down the toilet or poured into a drain.